In Accordance to section B, "Immediately prior to producing any cannabidiol oil or THC-A oil product, a pharmaceutical processor shall segregate all harvested Cannabis into homogenized batches. A pharmaceutical processor shall make a sample available from each batch for a laboratory to test for microbiological contaminants, mycotoxins, heavy metals, and pesticide chemical residue, and for purposes of conducting an active ingredient analysis." 

I suggest that "samples" (i.e., more than one sample) be made available due to the need most likely for more than one laboratory to perform all tests. Secondly, the storage of a small sample size may require additional requirements beyond a secure, cool, dry place (i.e., humidity and temperature controlled environment) to ensure stability.